Improving your Therapeutic Index Using Novel Nuclear Delivered ADCs
Time: 2:45 pm
day: Conference Day 2
Details:
- Discover how by understanding target biology, and careful tailoring of ADC design is the key to achieving high therapeutic index
- Learn the possibilities surrounding the use of AGX101 to increase the therapeutic index up to 10-fold
- Evaluate the use of nuclear-delivered antibody-drug conjugates, which are now in the clinic, to reduce toxicity
